Tagatose is a rare sugar that delivers the taste and functionality of conventional sugar while offering additional health benefits, including a lower glycemic response. Bonumose's scalable production method makes tagatose affordable for mass adoption in foods and beverages, supporting healthier product formulations without compromising quality.
Tagatose is a rare sugar that matches the taste and functional performance of conventional sugar while offering additional health benefits. Produced through Bonumose's scalable enzymatic method, tagatose can be manufactured cost-effectively, enabling its use as a mainstream sugar alternative in foods and beverages. This solution addresses the growing demand for healthier sweetening options that do not sacrifice flavor, texture, or processing behavior.
Key features:
The production process is designed to bring rare sugars into mainstream use, making healthier sweetening options accessible at scale.
Tagatose is already produced commercially through Bonumose's proprietary scalable method, and the company has established partnerships with food industry leaders to support mainstream adoption of rare sugars such as tagatose and allulose. The proposed research aims to generate additional validation data on tagatose's health benefits and functional properties, supporting expanded applications and regulatory positioning.
Bonumose is a startup specializing in innovative carbohydrate ingredients. It pioneered the affordable Tagatose production method and has built partnerships with food industry giants to bring rare sugars like Tagatose and Allulose into mainstream use for healthier foods.